Clinical Practice Resources
Dual Inhibition of ER+ Metastatic Breast Cancer: Anti-hormonal Therapy + CDK4/6 Inhibitor
Better understand the mechanism of action when combining anti-hormonal therapy and a CDK4/6 inhibitor as a dual inhibitor to treat metastatic breast cancer.